N/A N=50 Bariatric Surgery for Morbid Obesity
Obesity · Morbid Obesity
Primary: Size of Adipocytes — 73.4; 99.0; 103.0 µm
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=281 Maternal-Offspring Metabolics:Family Intervention Trial
Pregnancy · Weight Gain
Primary: Gestational Weight Gain (GWG) — 12; 10 kg — p=0.01
N/A N=42 Teaching Obesity Treatment Options to Adult Learners Trial
Obesity · Patient Education · Weight Loss
Primary: Recruitment — 42 Participants
Phase 1 N=22 PED NEONAT 20-000599 Fetal Body Composition
IUGR · Gestational Diabetes · Pregnancy Related
Primary: Maternal Visceral Adipose Tissue Volume — 97593; 169626; 96787 mm3
Phase 2 N=21 Pharmacokinetics of Oseltamivir Carboxylate In Morbidly Obese Subjects
Obesity
Primary: Steady-State AUC of Oseltamivir Carboxylate — 2579 hour*ng/mL
N/A N=81 Effects of Different Surgical Methods to Treat Obesity
Obesity · Type 2 Diabetes · Insulin Sensitivity
Primary: Insulin Sensitivity at 2 Years — 6.7; 6.6 glucose/kg body weight/min
Phase 4 N=109 Effect of Deep Neuromuscular Block on Surgical Conditions in Morbidly Obese Patients
Surgical Conditions
Primary: Surgical Rating — 4.2; 4.8 units on a scale — p=0.001
Phase 3 N=50 Safety and Efficacy of Adjustable Gastric Band Operations for Patients With Body Mass Index (BMI) Between 30-40 kg/m2
Obesity
Primary: To Determine Percent of Excess Weight Loss (%EWL) After Laparoscopic Adjustable Gastric Banding Surgery — 51.74 percentage of excess weight loss
N/A N=38 Targeting Obesity to Optimize Health in Cardiac Rehab (TOPCARE)
Obesity · Weight Loss · CHD - Coronary Heart Disease
Primary: Feasibility - Number of Enrolled Participants — 38 Participants
N/A N=360 Lifestyle and Pregnancy: The Clinical Effect of Lifestyle Intervention During Pregnancy in Obese Women
Maternal Obesity · Gestational Weight Gain · Obstetric Complications
Primary: Cesarean Section
N/A N=129 Weight Loss Physical Disabilities
Physical Disability
Primary: Weight Change in kg From Baseline to 6-months — -6.23; -8.16 kg
Phase 2 N=22 Fecal Microbiota Transplantation for the Treatment of Obesity
Obesity
Primary: Adverse Event Frequency — 11; 11; 1; 0 Participants
Phase 4 N=19 Single Dose PK of IV Tedizolid Phosphate in Morbidly Obese and Non-Obese Adults
Obesity
Primary: This Outcome Measure is the Tedizolid Area Under the Concentration Time-curve From Time 0 to 72 Hours in Morbidly Obese Subjects and Matched Non-obese Subjects. — 26.0…
N/A N=17 Tai Chi as Physical Activity for Women With Morbid Obesity
Morbid Obesity
Primary: Four Square Step Test — 9.91; 10.17; 8.93; 9.50 seconds
N/A N=264 Preventing Excessive Gestational Weight Gain in Obese Women
Obesity
Primary: Weight Gain Per Week of Observation — 0.39; 0.33 kg/wk
Phase 4 N=144 Surgical Conditions During Laparoscopic Bariatric Surgery
Morbid Obesity
Primary: Surgeon Satisfaction Scale — 2.7; 4.1; 3.1; 4.6 Scores on a scale
N/A N=47 Healthy Bodies, Healthy Kids
Child Mental Disorders · Obesity · Metabolic Syndrome
Primary: DEXA-measured Adiposity — 0.76; -0.43; -2.79 kilograms — p=0.01
N/A N=109 Using MOVE! With Seriously Mentally Ill Veterans
Mental Illness · Obesity
Primary: Weight Measurement — 237.2; 230.2; 240.8; 228.1 pounds — p=.720
Phase 4 N=236 Cervical Ripening for Obese Women: A Randomized, Comparative Effectiveness Trial
Obesity · Labor Induction · Cesarean Delivery
Primary: Number of Participants With a Need for Cesarean Delivery — 51; 53 Participants
N/A N=72 Determinants of Gestational Weight Gain in Obese Pregnant Women
Energy Intake · Energy Expenditure
Primary: Energy Intake — 2908; 2698; 2581 kilocalories per day
N/A N=47 Antecedents of Obesity: Fetal Measures of Adiposity
Obesity
Primary: Infant Adiposity at 24-72 Hours Following Birth — 11 Percentage of total body weight
N/A N=40 Assessment of Body Composition and Physical Function
Body Composition · Physical Function
Primary: Fat Mass — 44.71 Kg
Phase 2 N=20 Study to Evaluate ARD-101 in Adults With Obesity
Obesity
Primary: Relative Change in Body Weight (%) — -0.33; 0.38 Percentage of body weight change
N/A N=2,060 The Louisiana (LA) Health Project
Childhood Obesity
Primary: % Body Fat (Boys) — -1.3; -2.0; -0.11 percentage of body fat
N/A N=20 Multimodel Exercise and Weight Loss in Older Obese Veterans With Dysmobility
Obesity · Dysmobility
Primary: Change in 6 Minute Walk Distance — 1137; 1195 feet — p=0.03
N/A N=3,169 MOVE OUT: A Partnership With Veterans Groups to Enhance Weight Management in the Veterans Health Administration (VHA)
Obesity · Overweight · Hypertension
Primary: Change in Weight (From Baseline) — -0.71; -0.31; -1.64; -1.06 Pounds — p=0.4937
N/A N=20 Bariatric Embolization of Arteries for the Treatment of Obesity
Morbid Obesity
Primary: Percent Weight Change — 11.5 percentage of excess weight loss
Phase 2 N=30 Topiramate in Adolescents With Severe Obesity
Obesity, Morbid · Obesity · Weight Loss
Primary: Percent Change From Baseline in Body Mass Index at 28-Weeks — -2.74; -0.85 % change BMI
N/A N=5,392 Impact of Body Weight on the Immediate Health of the Pediatric Population
Childhood Obesity
Primary: Diagnosis of Infectious Disease — 900; 1067 Participants — p=.026
N/A N=106 "Mandometer®" Study for Managing Childhood Obesity
Childhood Obesity
Primary: BMI SDS or Z-score — 3.29; 3.21; 2.93; 3.07 Z-Score